ArticleJournal of cellular and molecular medicine2024

Farrerol alleviates insulin resistance and hepatic steatosis of metabolic associated fatty liver disease by targeting PTPN1.

Jingwen Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.